Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
Laidlaw TM, Menzies-Gow A, Caveney S, et al. J Asthma Allergy. 2023;16:915–932. The authors have advised there is an error in Figure 1 on page 922. The n= x-axis data were transposed for the treatment groups for both the Patients with NPs and Patients without NPs. The correct Figure 1 is as follows. Figure 1 AAER over 52 weeks in patients with or without nasal polyps in the 2 years before randomization in the NAVIGATOR study.Abbreviations: AAER, annualized asthma exacerbation rate; CI, confidence interval; NP, nasal polyp; Q4W, every 4 weeks.Note: n, number of patients contributing to the analysis. The authors apologize for this error..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Journal of Asthma and Allergy - (2023), Seite 1053-1054 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Laidlaw TM [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Themen: |
Chronic rhinosinusitis |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ090676734 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ090676734 | ||
| 003 | DE-627 | ||
| 005 | 20240414085717.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ090676734 | ||
| 035 | |a (DE-599)DOAJf39e39ecd9bc43bfbcd7c8d3c3530b01 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC581-607 | |
| 100 | 0 | |a Laidlaw TM |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum] |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Laidlaw TM, Menzies-Gow A, Caveney S, et al. J Asthma Allergy. 2023;16:915–932. The authors have advised there is an error in Figure 1 on page 922. The n= x-axis data were transposed for the treatment groups for both the Patients with NPs and Patients without NPs. The correct Figure 1 is as follows. Figure 1 AAER over 52 weeks in patients with or without nasal polyps in the 2 years before randomization in the NAVIGATOR study.Abbreviations: AAER, annualized asthma exacerbation rate; CI, confidence interval; NP, nasal polyp; Q4W, every 4 weeks.Note: n, number of patients contributing to the analysis. The authors apologize for this error. | ||
| 650 | 4 | |a chronic rhinosinusitis | |
| 650 | 4 | |a nasal polyps | |
| 650 | 4 | |a snot-22 | |
| 650 | 4 | |a thymic stromal lymphopoietin | |
| 653 | 0 | |a Immunologic diseases. Allergy | |
| 700 | 0 | |a Menzies-Gow A |e verfasserin |4 aut | |
| 700 | 0 | |a Caveney S |e verfasserin |4 aut | |
| 700 | 0 | |a Han JK |e verfasserin |4 aut | |
| 700 | 0 | |a Martin N |e verfasserin |4 aut | |
| 700 | 0 | |a Israel E |e verfasserin |4 aut | |
| 700 | 0 | |a Lee JK |e verfasserin |4 aut | |
| 700 | 0 | |a Llanos JP |e verfasserin |4 aut | |
| 700 | 0 | |a Martin N |e verfasserin |4 aut | |
| 700 | 0 | |a Megally A |e verfasserin |4 aut | |
| 700 | 0 | |a Parikh B |e verfasserin |4 aut | |
| 700 | 0 | |a Vong S |e verfasserin |4 aut | |
| 700 | 0 | |a Welte T |e verfasserin |4 aut | |
| 700 | 0 | |a Corren J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Asthma and Allergy |d Dove Medical Press, 2009 |g (2023), Seite 1053-1054 |w (DE-627)DOAJ000104191 |x 11786965 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g pages:1053-1054 |
| 856 | 4 | 0 | |u https://doaj.org/article/f39e39ecd9bc43bfbcd7c8d3c3530b01 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.dovepress.com/corrigendum-tezepelumab-efficacy-in-patients-with-severe-uncontrolled--peer-reviewed-fulltext-article-JAA |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1178-6965 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2023 |h 1053-1054 | ||